Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypersensitivity × Mammography × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 48 Disease 5 Obesity 2 Women With Breast Cancer 1 Prostatic Neoplasms 1 Obesity, Morbid 1 Neoplasms 1 Mammary Neoplasms, Animal 1 Hypersensitivity 1 Fibrocystic Breast Disease 1 Cysts 1 Colorectal Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Screening 1 Breast Cancer Screening 1 Breast Cancer Detection 1 Asymptomatic 1 Acquired Immunodeficiency Syndrome 1

Interventions

Dexamethasone 3 iniparib 2 Ultrasonography 2 Poly(ADP-ribose) Polymerase Inhibitors 2 Calcium Dobesilate 2 tislelizumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 asparaginase erwinia chrysanthemi recombinant 1 amminedichloro(2-methylpyridine)platinum(II) 1 ZD4054 1 Vincristine 1 Rituximab 1 Paclitaxel 1 Narrow Band Imaging 1 Methotrexate 1 Mammography 1 Lenalidomide 1 Immune Checkpoint Inhibitors 1 High-Energy Shock Waves 1 Doxorubicin 1 Dexrazoxane 1 Cytarabine 1 Cetirizine 1 Carboplatin 1 Blood Specimen Collection 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02909426 2021-10-07

MUST-BE

Soonchunhyang University Hospital

11,880 enrolled

Carcinoma, Intraductal, Noninfiltrating, Hypersensitivity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡